XML 24 R4.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Statements of Income - USD ($)
shares in Thousands
12 Months Ended
May 31, 2024
May 31, 2023
May 31, 2022
Income Statement [Abstract]      
Net Sales [1] $ 7,335,277,000 $ 7,256,414,000 $ 6,707,728,000
Cost of Sales 4,320,688,000 4,508,370,000 4,274,675,000
Gross Profit 3,014,589,000 2,748,044,000 2,433,053,000
Selling, general and administrative expense 2,113,585,000 1,956,040,000 1,788,284,000
Restructuring Expense 30,008,000 15,465,000 6,276,000
Goodwill Impairment 0 36,745,000 0
Interest Expense 117,969,000 119,015,000 87,928,000
Investment (Income) Expense, Net (44,974,000) (9,748,000) 7,595,000
(Gain) on Sales of Assets and Business, Net 0 (28,632,000) (51,983,000)
Other Expense (Income), Net 10,164,000 9,777,000 (11,846,000)
Income Before Income Taxes 787,837,000 649,382,000 606,799,000
Provision for Income Taxes 198,395,000 169,651,000 114,333,000
Net Income 589,442,000 479,731,000 492,466,000
Less: Net Income Attributable to Noncontrolling Interests 1,045,000 1,040,000 985,000
Net Income Attributable to RPM International Inc. Stockholders $ 588,397,000 $ 478,691,000 $ 491,481,000
Average Number of Shares of Common Stock Outstanding:      
Basic 127,767 127,507 127,948
Diluted [2] 128,340 128,816 129,580
Earnings per Share of Common Stock Attributable to RPM International Inc. Stockholders:      
Basic $ 4.58 $ 3.74 $ 3.81
Diluted $ 4.56 $ 3.72 $ 3.79
[1] It is not practicable to obtain the information needed to disclose revenues attributable to each of our product lines.
[2] The dilutive effect of performance-based restricted stock units is included when they have met minimum performance thresholds. The dilutive effect of SARs includes all outstanding awards except awards that are considered antidilutive. SARs are antidilutive when the exercise price exceeds the average market price of the Company’s common shares during the periods presented. For the years ended May 31, 2024, 2023 and 2022, approximately 260,000, 750,000 and 655,000 shares of stock, respectively, granted under stock-based compensation plans were excluded from the calculation of diluted EPS, as the effect would have been anti-dilutive.